Metabolic dysfunction-related liver disease as a risk factor for cancer
Objective The aim of this study was to investigate the association between obesity, diabetes and metabolic related liver dysfunction and the incidence of cancer.Design This study was conducted with health record data available from the National Health Service in Tayside and Fife. Genetics of Diabete...
Saved in:
| Main Authors: | John F Dillon, Ewan R Pearson, Colin N A Palmer, Alasdair Taylor, Moneeza K Siddiqui, Philip Ambery, Javier Armisen, Benjamin G Challis, Carolina Haefliger, Alex S F Doney |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-11-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/9/1/e000817.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liver Dysfunction in Hyperthyroidism
by: Khongsaengbhak T, et al.
Published: (2024-11-01) -
Clinical and pharmacogenomic predictors of survival in tamoxifen treated breast cancer female patients: a real-world study
by: Abdullah R. Al-Matrafi, et al.
Published: (2025-06-01) -
COVID-19 and liver dysfunction
by: Shashidhar K N, et al.
Published: (2021-06-01) -
Cognitive dysfunction in patients with non-alcoholic fatty liver disease
by: S. A. Smakotina, et al.
Published: (2025-06-01) -
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver diseaseKeypoints
by: Robert F. Schwabe, et al.
Published: (2025-08-01)